Aptose Biosciences Inc.

Quick facts

Phase 3 pipeline

• Virulizin® · Oncology
  Virulizin is an oncolytic virus therapy that selectively infects and destroys cancer cells while sparing normal tissue.

Phase 1 pipeline

• Azacitidine for Intravenous Infusion
• LOR-253 HCl

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Aptose Biosciences Inc. portfolio CI brief
• Aptose Biosciences Inc. pipeline updates RSS